<p>Anti IgY in the sera of mice immunized with normal IgY (IgY immunized), treated once intranasally with PR8-specific IgY 8 hours before (anti PR8 IgY −8 h) or three times after infection (anti PR8 IgY +8, 32, 56 h) (Fig. 4A). Endpoint titers (log<sub>2</sub>) were determined by ELISA. Morbidity and mortality of IgY-immunized mice treated with PR8-specific IgY (anti PR8 IgY) before (−6 hr) or after (+6 hr) infection with mouse-adapted PR8 (Fig. 4B). The values are the mean of 5–10 mice in each group.</p
<p>Groups of 5 B6 mice were treated with purified (A) anti-Ly6G (1A8) or (B) anti-Gr-1 (RB6-8C5) ant...
<p>Sera of 10 immunized mice per group were collected on days 15, 30, 45, 60, 75 and 90 after the fi...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p>BALB/c mice were treated with PR8-specific IgY (anti PR8 IgY) - as described in <a href="http://w...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>(a) J8-specific serum IgG concentrations in donor BALB/c or recipient SCID mice. Serum samples we...
<p>(A) Female BALB/c mice were immunized with rSEB plus AlPO<sub>4</sub> adjuvant, AlPO<sub>4</sub> ...
<p>(a-g) Mice were immunized once i.d. with 25 µg DNA/EP as indicated (n = 6/group), and assayed for...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>(<b>A</b>) 9 V/null mice that received Vela (solid bars) or Imig (open bars) were bled prior to e...
<p>Three, 8-week old C3H/HeN mice were intravenously immunized with 50 µg of hTg in 100 µl of PBS in...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>BALB/c mice (n = 4) were infected with a lethal dose (500 pfu in 50 µl) of PR8 virus via the TRT ...
<p>Groups of 5 B6 mice were treated with purified (A) anti-Ly6G (1A8) or (B) anti-Gr-1 (RB6-8C5) ant...
<p>Sera of 10 immunized mice per group were collected on days 15, 30, 45, 60, 75 and 90 after the fi...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...
<p>BALB/c mice were treated with PR8-specific IgY (anti PR8 IgY) - as described in <a href="http://w...
<p>(a) J8-specific IgG concentrations in serum of individual donor and recipient mice are shown, wit...
<p>B6 mice were injected i.m. in both hind-legs with PBS (closed triangles) or a total of 10 µg of N...
<p>Serum anti-influenza IgG antibody titers. Serum influenza specific IgG titers (ng/ml). The immuni...
<p>(a) J8-specific serum IgG concentrations in donor BALB/c or recipient SCID mice. Serum samples we...
<p>(A) Female BALB/c mice were immunized with rSEB plus AlPO<sub>4</sub> adjuvant, AlPO<sub>4</sub> ...
<p>(a-g) Mice were immunized once i.d. with 25 µg DNA/EP as indicated (n = 6/group), and assayed for...
BALB/c mice (n = 10/group) were immunized i.m. with HBsAg (2 μg) with or without adjuvant on days 0 ...
<p>(<b>A</b>) 9 V/null mice that received Vela (solid bars) or Imig (open bars) were bled prior to e...
<p>Three, 8-week old C3H/HeN mice were intravenously immunized with 50 µg of hTg in 100 µl of PBS in...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>BALB/c mice (n = 4) were infected with a lethal dose (500 pfu in 50 µl) of PR8 virus via the TRT ...
<p>Groups of 5 B6 mice were treated with purified (A) anti-Ly6G (1A8) or (B) anti-Gr-1 (RB6-8C5) ant...
<p>Sera of 10 immunized mice per group were collected on days 15, 30, 45, 60, 75 and 90 after the fi...
<p>(A–E) Antibody titers elicited by vaccination with DM-C. Six mice per groups were vaccinated with...